Literal source text
Lobbying issues and bill citations
MMM · Medicare/Medicaid
General issues related to Medicare and Medicaid, including: Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order; Part D Program; enter for Medicare and Medicaid Innovation (CMMI) Drug Pricing Demonstration Programs; drug pricing, PBM reform; H.R. 6130 / S. 3267, the Alzheimers Screening and Prevention (ASAP) Act; H.R. 4752 / S. 2379, the Concentrating on High-value Alzheimers Needs to Get to an End (CHANGE) Act; H.R. 3747, the Accelerating Access to Dementia and Alzheimers Provider Training (AADAPT) Act
Literal federal measure citations: H.R. 6130, S. 3267, H.R. 4752, S. 2379, H.R. 3747
TAX · Taxation/Internal Revenue Code
Tax reform, including: H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation.
Literal federal measure citations: H.R.1
TRD · Trade (domestic/foreign)
Issues related to supply chain manufacturing and tariffs, including: the Section 232 and Section 301 tariff investigations related to branded pharmaceuticals.
CPT · Copyright/Patent/Trademark
Issues related to pharmaceutical Intellectual Property (IP), including: S. 2658, Medication Affordability and Patent Integrity Act.
Literal federal measure citations: S. 2658
MAN · Manufacturing
Issues related to pharmaceutical manufacturing.
HCR · Health Issues
Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; pharmaceutical scheduling; Pharmacy Benefit Manager (PBM) reform, 340B Drug Discount Program; H.R.9599 Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act (SECURE 340B Act)
Literal federal measure citations: H.R.9599
